⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9193625 | 0.78 | — | — | |
| SCHEMBL773672 | 0.75 | TSHR (0.45) | — | |
| SCHEMBL430310 | 0.73 | — | — | |
| SCHEMBL28557026 | 0.72 | — | — | |
| SCHEMBL7212473 | 0.72 | — | — | |
| SCHEMBL691825 | 0.72 | — | — | |
| SCHEMBL6362965 | 0.71 | — | — | |
| SCHEMBL624721 | 0.71 | — | — | |
| SCHEMBL5194011 | 0.71 | — | — | |
| SCHEMBL27356622 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240101996-A1 | Enzymes Entrapped in Organopolysiloxane Matrix | JL BIOSCIENCES, INC. | 2024-03-28 | — | — | US | claimed |
| WO-2022115460-A1 | ENZYMES ENTRAPPED IN ORGANOPOLYSILOXANE MATRIX | JL BIOSCIENCES, INC. (US) | 2022-06-02 | — | — | WO | claimed |
| US-20200062753-A1 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2020-02-27 | — | — | US | claimed |
| US-10428069-B2 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2019-10-01 | — | — | US | claimed |
| EP-3114128-B1 | NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | HOFFMANN LA ROCHE (CH) | 2019-01-02 | — | — | EP | claimed |
| US-20180370969-A1 | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2018-12-27 | — | — | US | claimed |
| US-10081627-B2 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2018-09-25 | — | — | US | claimed |
| EP-3114128-A1 | NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. Hoffmann-La Roche AG (CH) | 2017-01-11 | — | — | EP | claimed |
| US-20160083383-A1 | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2016-03-24 | — | — | US | claimed |
| US-9233978-B2 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2016-01-12 | — | — | US | claimed |
| WO-2015132276-A1 | NOVEL 6-FUSED HETEROARYLDIHYDROPYRIMIDINES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION | F. HOFFMANN-LA ROCHE AG (CH) | 2015-09-11 | — | — | WO | claimed |
| US-20150252057-A1 | Novel 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2015-09-10 | — | — | US | claimed |
| EP-1023431-B1 | HARD SURFACE CLEANING COMPOSITIONS COMPRISING MID-CHAIN BRANCHED SURFACTANTS | PROCTER & GAMBLE (US) | 2004-12-15 | — | — | EP | claimed |
| EP-0888440-B1 | GLASS CLEANING COMPOSITIONS CONTAINING BLOOMING PERFUME | PROCTER & GAMBLE (US) | 2003-01-29 | — | — | EP | claimed |
| EP-0888433-B1 | GLASS CLEANER COMPOSITIONS HAVING GOOD FILMING/STREAKING CHARACTERISTICS CONTAINING AMINE OXIDE POLYMERS FUNCTIONALITY | PROCTER & GAMBLE (US) | 2002-11-13 | — | — | EP | claimed |
| EP-0804536-B1 | GLASS CLEANER COMPOSITIONS | PROCTER & GAMBLE (US) | 2000-01-12 | — | — | EP | claimed |
| WO-1998035677-A1 | NON-SEDATING HISTAMINE ANTAGONIST COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | BRIDGE PHARMA, INC. (US) | 1998-08-20 | — | — | WO | claimed |
| EP-0531382-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1993-03-17 | — | — | EP | claimed |
| WO-1991018888-A1 | N-SUBSTITUTED-1,2,4-TRIAZOLONE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS | G.D. SEARLE & CO. (US) | 1991-12-12 | — | — | WO | claimed |
| US-4126587-A | Cleaning agents for contact lenses | BARNES-HIND PHARMACEUTICALS, INC. (US) | 1978-11-21 | — | — | US | claimed |